What is Nektar Therapeutics's current ratio?

Nektar Therapeutics (NKTR) reported current ratio of 10.2× in Q1 2026.

How has Nektar Therapeutics's current ratio changed year-over-year?

Nektar Therapeutics's current ratio increased by 214.9% year-over-year, from 3.2× to 10.2×.

What is the long-term trend for Nektar Therapeutics's current ratio?

Over 5 years (2020 to 2025), Nektar Therapeutics's current ratio has grown at a -12.7% compound annual growth rate (CAGR), from 9.8× to 5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Nektar Therapeutics NKTR Current ratio

Current ratio at other companies

AmgenAMGN

1.3×+0.1×

Regeneron PharmaceuticalsREGN

3.6×-1.4×

ImmunityBio, Inc.IBRX

6.7×+4.4×

Apogee Therapeutics, Inc.APGE

32.6×+16.8×

ImmunomeIMNM

21.7×+11.2×

Vera TherapeuticsVERA

13.6×-14.0×

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

total current assets/total current liabilities=10.2×

Based on the most recent quarter.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's current ratio?: Nektar Therapeutics (NKTR) reported current ratio of 10.2× in Q1 2026.
How has Nektar Therapeutics's current ratio changed year-over-year?: Nektar Therapeutics's current ratio increased by 214.9% year-over-year, from 3.2× to 10.2×.
What is the long-term trend for Nektar Therapeutics's current ratio?: Over 5 years (2020 to 2025), Nektar Therapeutics's current ratio has grown at a -12.7% compound annual growth rate (CAGR), from 9.8× to 5×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.